Company: VCYT
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001384101-25-000060
Chunk: 13

Company: VERACYTE, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
Item 1. Condensed Consolidated Financial Statements-(Unaudited)

VERACYTE, INC. 

Condensed Consolidated Balance Sheets 

(unaudited)

(In thousands, except share and par value amounts)

 March 31, 2025December 31, 2024  (See Note 1)Assets  Current assets:  Cash and cash equivalents$186,120 $239,087 Short-term investments101,235 50,354 Accounts receivable53,781 46,525 Supplies and inventory24,254 21,750 Prepaid expenses and other current assets17,762 14,551 Total current assets383,152 372,267 Property, plant and equipment, net22,529 22,953 Right-of-use assets, operating leases47,624 48,189 Intangible assets, net99,094 102,301 Goodwill754,272 745,800 Restricted cash1,645 1,544 Other assets7,095 6,981 Total assets$1,315,411 $1,300,035 Liabilities and Stockholders’ EquityCurrent liabilities:Accounts payable$15,709 $8,634 Accrued liabilities35,928 43,826 Current portion of deferred revenue1,712 1,673 Current portion of acquisition-related contingent consideration14,360 16,981 Current portion of operating lease liabilities7,409 7,500 Current portion of other liabilities7 19 Total current liabilities75,125 78,633 Deferred tax liabilities1,242 1,227 Acquisition-related contingent consideration, net of current portion570 561 Operating lease liabilities, net of current portion43,092 43,237 Other liabilities446 411 Total liabilities120,475 124,069 Commitments and contingenciesStockholders’ equity:Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024— — Common stock, $0.001 par value; 125,000,000 shares authorized, 78,306,356 and 77,772,678 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively78 78 Additional paid-in capital1